Celldex Therapeutics, Inc.
| Nasdaq: CLDX
Celldex Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. Its lead drug candidates include rindopepimut, glembatumumab vedotin and varlilumab. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.